Suven Pharmaceuticals Cash Flow Annual

Trade
BSE: 543064 | NSE: SUVENPHAR | ISIN: INE03QK01018 | Sector: Biotechnology & Drugs
633.35 +11.65 (1.87%)Updated : 23 May 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Net Income/ Starting Line 559.73667.59467.67404.51
Depreciation/ Depletion 46.4638.2631.2223.68
Non- Cash Items -15.122.385.2628.94
Changesin Working Capital -140.16-378.22-121.61-41.18
Cashfrom Operating Activities 450.91330.00382.55415.95
Capital Expenditures -285.77-75.19-110.85-99.41
Other Investing Cash Flow Items Total 90.93-61.02-200.55-322.11
Cashfrom Investing Activities -194.84-136.21-311.40-421.53
Financing Cash Flow Items -5.44-6.14-8.67-20.32
Total Cash Dividends Paid -203.65-101.83-25.46-76.72
Issuance( Retirement)of Debt Net -26.74-48.45-41.53103.41
Cashfrom Financing Activities -235.83-156.41-75.666.37
Foreign Exchange Effects 0.000.000.00-
Net Changein Cash 20.2437.38-4.510.79
Cash Interest Paid 5.446.238.9220.32
Cash Taxes Paid 145.79184.26109.4486.41
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,150.90+23.20(2.06%)
3,524.70+64.55(1.87%)
HomeMarketsPremiumFor youGet App